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ABSTRACT 
A variety of vasoregulatory systems are involved in the complex control of blood flow in 
human skeletal muscle. The interaction between these systems where one system can 
override or modify the other makes blood flow regulation complicated. Determinations of 
muscle blood flow can thus be challenging especially when considering the shortcomings 
and limitations of the available measurement methods. This thesis focuses on two different 
topics of which both are dependent on sympathetic tone.  
 
First, the common use of venous occlusion plethysmography (VOP) with only one strain 
gauge attached per limb is a method with obvious pitfalls. The inherent problems with this 
simplification of the original VOP method are highlighted in Study I-II where small variations 
in sympathetic tone and venous pressure proved to have a considerable influence on the 
results. The basic circumstance to this variability is the curvo-linear pressure/volume 
relationship in the veins and the fact that redistribution of blood can occur between 
individual limb segments. The results clearly demonstrate that events taking place under 
one strain gauge cannot be strictly duplicated in adjacent portions of the limb.  
 
Secondly, recent reports have indicated that a minor muscle trauma might change the local 
blood flow response to adrenaline. Two studies were conducted to test if an acute small 
muscle injury (Study III) and chronic muscle damage (Study IV) influences the normal blood 
flow effect of adrenaline. In support of the hypothesis we found that the microdialysis 
catheter-induced muscle injury in Study III caused a significant vasoconstriction during an i.v. 
adrenaline infusion, as measured with 133Xenon clearance next to the catheter, whereas no 
significant change in blood flow was seen with adrenaline-infusion in the absence of the 
catheter (conventional 133Xe administration). The adverse adrenaline effect is likely to be 
related to the degree of invasiveness. Hence, it would be expected that any type of invasive 
measuring device causing a muscle injury could possibly provoke a similar reaction. This 
finding has a general physiological implication, but has also implications for the use of 
invasive techniques to study blood flow regulation in skeletal muscle.  
Previous studies of tennis elbow (TE) have reported signs of diffuse muscle damage and 
decreased blood flow in the affected extensor carpi radialis brevis (ECRB) muscle. We 
conducted a case-control study (IV) to test the hypothesis that the muscle damage in the ECRB 
in TE alters the blood flow response to adrenaline in a vasoconstrictory direction. Muscle 
blood flow was determined with local clearance of 99mTechnetium during an i.v. infusion of 
adrenaline. In support of the hypothesis, the blood flow reaction to adrenaline was markedly 
different in the two study groups. Whereas the infusion did not significantly influence 
99mTechnetium-clearance in the ECRB of controls there was a significantly decreased clearance 
in the patients. The altered adrenaline effect indicates a vascular dysregulation in TE, which is 
likely to be of clinical significance by contributing to the development and maintenance of the 
chronic muscle pain in this large patient group. Whether the vasoregulatory alteration, which 
would be expected to involve recurring relative muscle ischemia, represents the primary 
aetiology in TE or is a secondary effect of the muscle injury cannot be determined.  
In conclusion, a small muscle injury, acute or chronic, seems to alter the effect of adrenaline 
on skeletal muscle blood flow in a vasoconstrictory direction. 
 
Key words: adrenaline, blood flow, blood redistribution, ischemia, muscle injury, skeletal 
muscle, strain-gauge plethysmography, sympathetic tone, transmural pressure, 
99mTechnetium clearance, tennis elbow, venous compliance, venous occlusion 
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THESIS AT A GLANCE 
I) VENOUS OCCLUSION PLETHYSMOGRAPHY (VOP) – LOWER EXTREMITY 
Can events taking place under one strain gauge be strictly duplicated in adjacent 
portions of the limb and be representative as blood flow in the whole limb? 
Study design: 6 healthy subjects, 4 strain gauges at different levels of the lower limb, 
varying room temperature (warm, normal, cold) and varying leg position (up, 
horizontal, down). 
VOP in its modern form, measuring volume expansion rate over an isolated limb 
segment, is associated with problems due to the curvo-linear pressure/volume 
relationship in the veins and the fact that redistribution of blood can occur between 
individual limb segments. The curvo-linear relationship between the transmural 
pressure (p) and the venous volume (v) furthermore changes with an increasing 
sympathetic tone. When the veins are in a relaxed state, the curve is S-shaped with a 
lower slope of the p/v curve at high transmural pressure than at low pressure. In 
contracted veins, the curve is shifted to the right, resulting in an increased venous 
pressure and lower venous volume. Depending on the position of the limb and 
whether the veins are in a relaxed or contracted state at the time of venous occlusion 
the obtained results will thus differ. 
 
II) VOP – UPPER EXTREMITY, SPECIAL ATTENTION ON HAND CIRCULATION 
Does the hand circulation influence the results of VOP with strain gauge technique? 
Study design: 6 healthy subjects, 3 strain gauges at different levels of the forearm, 
varying room temperature (warm, normal, cold) and varying arm position (up, 
horizontal, down). Half of the measurements with, and half without, hand circulation. 
The curvo-linear pressure/volume relationship in the veins causes similar problems to 
the VOP technique in the upper extremity as shown in the lower extremity (Study I). 
The usage or non-usage of a distal wrist cuff during VOP for exclusion of hand 
circulation influences the results in several aspects. With included hand circulation the 
highest expansion rate was found in the distal segment at normal and high 
temperatures, but in the proximal segment at low temperature. This pattern was 
found with all arm positions. With excluded hand circulation, there was a significant 
two factor interaction between arm position – strain gauge position, which was 
independent of temperature. The highest expansion rate was found in the proximal 
segment when the arm was elevated, but in the distal segment when the arm was 
lowered.  
Conclusion Study I-II 
VOP is frequently used with only one strain gauge attached to the limb and the results 
obtained is referred to as blood flow in the limb. Placement of the strain gauge at the 
maximal circumference of the limb with a distal occlusion cuff at the level of the wrist 
or ankle is regarded as standard in this technique. However, even if the procedure is 
standardized in this manner, events taking place under one strain gauge cannot be 
strictly duplicated in adjacent portions of the limb. Small variations in sympathetic 
tone and venous pressure can influence blood flow measurements with the VOP 
technique, even in intra-individual comparisons. This variability should be taken into 
account when strain-gauge plethysmography is applied for limb blood flow 
determination, especially in interventional studies. 
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III) SMALL MUSCLE INJURY - ALTERED EFFECT OF ADRENALINE 
Can a small muscle injury change the balance of vasodilatory and vasoconstrictory 
influences of adrenaline (ADR)? 
Study design: Healthy subjects (n=8), blood flow was measured by 133Xe (Xenon) 
clearance in the gastrocnemius muscle. Two ways of 133Xe administration; 
conventional intramuscular injection using a thin needle or through a fine tube close 
to an intramuscular microdialysis catheter  
Intervention: ADR infusion or placebo infusion.  
Expt 1 – conventional 133Xe administration – ADR infusion. 
Expt 2 – 133Xe close to a microdialysis catheter – ADR infusion. 
Expt 3 – 133Xe close to a microdialysis catheter – Placebo infusion. 
The microdialysis catheter-induced muscle trauma alters the balance of vasodilatory 
and vasoconstrictory influences of ADR in a vasoconstrictive direction. The adverse 
ADR effect is likely to be related to the degree of invasiveness and/or the presence of 
the catheter. Further studies are needed to find out if any type of invasive measuring 
device causing a muscle injury is able to provoke a similar reaction.  
This finding in has a general physiological implication, but has also implications for the 
use of invasive techniques to investigate blood flow regulation in skeletal muscle. 
 
IV) CHRONIC MUSCLE DAMAGE - ALTERED EFFECT OF ADRENALINE 
Can chronic muscle damage change the balance of vasodilatory and vasoconstrictory 
influences of adrenaline (ADR)? 
Study design: Healthy subjects (n=8), Patients suffering from tennis elbow (TE) (n=8). 
Blood flow was measured by 99mTechnetium-clearance in the main portion of the 
ECRB muscle. 
Intervention: ADR infusion 
The blood flow reaction to adrenaline was markedly different in the two study groups. 
Whereas the infusion did not significantly influence 99mTechnetium-clearance in the 
ECRB of controls there was a significant decrease in the patients. The altered 
adrenaline effect indicates a vascular dysregulation in TE, which is likely to be of 
clinical significance by contributing to the development and maintenance of the 
chronic muscle pain in this large patient group. Whether the vasoregulatory 
alteration, which would be expected to involve recurring relative muscle ischemia, 
represents the primary aetiology in TE or is a secondary effect of the muscle injury 
cannot be determined.  
 
Conclusion study III-IV 
In conclusion, a small muscle injury, acute or chronic, seems to alter the effect of ADR 
on skeletal muscle blood flow in a vasoconstrictory direction. 
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1 INTRODUCTION 
1.1 BACKGROUND 
Blood flow determinations in human skeletal muscle are not easily made. The 
different measuring methods available are connected with various individual 
problems and the “perfect” method is yet to be invented. The reasons for these 
individual limitations and disadvantages are heterogeneous. Venous occlusion 
plethysmography (VOP) is a commonly used, non invasive, method for determination 
of limb blood flow [1]. VOP in its modern form, measuring volume expansion rate over 
an isolated limb segment, is associated with problems due to the curvo-linear 
pressure/volume relationship in the veins and the fact that redistribution of blood can 
occur between individual limb segments. The inert gas clearance method [2], in which 
a radioactive tracer is injected into the muscle (e.g. Xenon clearance) is restricted due 
to the radioactivity involved and due to limitations during prolonged measurements 
[3]. Methods employing insertion of a measuring device into the muscle are obviously 
more invasive simply due to the caliber of the device and the fact that the instrument 
remains inside the muscle during the procedure, e.g. the microdialysis ethanol 
technique [4]. A concern in this instance is the trauma inflicted to the muscle by the 
insertion of the device which may influence the fine tuned control of the local 
circulation and hence possibly the accuracy of the method. In fact, recent reports have 
indicated that the insertion of a microdialysis catheter might change the local blood 
flow response to adrenaline (ADR) [5,6]. The purpose of the investigations in this 
thesis has been to study blood flow regulation in human skeletal muscle, with 
different methods, under normal conditions and after a minor muscle trauma. Special 
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emphasis has been put on the ADR induced blood flow reaction and if a minor muscle 
injury in some way alters this effect.  
 
1.2 CONTROL OF BLOOD VESSELS 
A variety of vasoregulatory systems are involved in the complex control of local blood 
flow. To simplify, these systems can be divided into a hierarchy of three control 
systems, each able to override or modify the lower one [7]. The lowest level of control 
is the local myogenic auto-control, generating basal tone in resistance vessels. The 
second level of control is maintained by local factors such as adenosine, lactate and 
NO etc. regulating local blood flow to match the metabolic or circulatory demands of 
the tissue; for example in an exercising muscle. The third level of control is the 
neuroendocrine system which generates central and reflex control to the vascular 
system in favor for the organism as a whole, e.g. blood pressure stabilization. This 
level is made up by sympathetic nerve fibers (noradrenaline) and hormonal control 
(ADR, angiotensin II and vasopressin). 
 
1.3 ADRENALINE 
The sympathetic nervous system, and the balance between its α- and β-effects, is a 
vital part of the blood flow control in skeletal muscle. Representing the hormonal part 
of the sympathetic nervous system, ADR contributes as one of our most potent 
regulators of blood flow. The different locations and relative abundance of the 
adrenergic receptors in the body is an important but complex matter to appreciate 
when the ADR effect on muscle blood flow is discussed. 
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1.3.1 Historical background 
The first pure extract of ADR was produced by the Japanese chemist Jokichi Takamine 
in 1901 who patented the formulation under the name “Adrenalin” [8,9]. (Latin:  ad = 
“near”, renes = “kidneys”). ADR was first synthesized by Stolz [10] and Dakin [11], 
independently, in 1904. After studying synthetic amines related to ADR, Barger and 
Dale in 1910 came close to discover noradrenalin (NADR) being the 
sympathomimetic nerve transmitter [9,12]. They showed that the effects of 
sympathetic nerve stimulation are more closely reproduced by the injection of 
sympathomimetic primary amines than by ADR or secondary amines [9]. However, it 
took until 1946 before NADR finally was identified by von Euler [13]. Subsequently 
Ahlquist, in 1948 [14], examined the effects of ADR, NADR and Isoprenaline (a 
synthetic catecholamine) and postulated the existence of two types of receptors; 
alpha (α) and beta (β), since the effect of these catecholamines fell into two distinct 
patterns (fig 1). Various α-receptor antagonists were known at that time but selective 
β-receptor antagonists were not developed until about ten years later [15]. By the use 
of these selective receptor antagonists Ahlquist’s classification could be confirmed 
[16-18]. Further subdivision into α1, α2, β1 and β2 receptors followed [19]. In 1974, the 
hypothesis of presynaptic autoreceptors modulating the sympathetic effect was 
described by Langer [9,20] (see paragraph 1.3.2) and was later verified [18,21].  During 
the following about fifteen years the subclassification of the receptors came to rely on 
anatomical or functional characteristics. Recently, by identification of potent and 
highly selective α1- and α2-adrenoceptor agonists and antagonists, subclassification 
based on pharmacological properties has been found to be more appropriate [18]. 
Consequently, the historical classification into two major subtypes, α- and β- 
receptors, has been revised into three major types: α1-, α2- and β-receptors based on 
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three lines of evidence; their affinity of selective drugs, difference in second 
messenger response and predicted amino acid sequences of the receptors [18]. 
Further subdivisions of each of the three major types of receptors have been 
proposed [18,22,23]. The constellation of the adrenergic receptors and their individual 
location are thus complex and further knowledge is constantly evolving (fig 1). 
 
 
Figure 1. The original (top) and current (bottom) classifications of adrenergic receptors, emphasizing the 
early and prominent role of Ahlquist's 1948 paper.  
Ahlquist RP.  Am J Physiol 1948 [14]. Bylund DB. The Adrenergic Receptors in the 21st Century,: 
Humana, 2005 [24].  Bylund DB. Am Physiol Soc. Am J Physiol Endocrinol Metab , 2007[25], used with 
permission.  
 
1.3.2 Adrenergic receptor location 
It was originally believed that the α1/α2 classification corresponded directly with the 
post- and pre-synaptic location of the receptors [26]. Several exceptions to this are 
now known. In blood vessels, the postsynaptic α1-receptor is the predominant 
postsynaptic receptor, mediating vasoconstriction [27]. In addition, the postsynaptic  
   7 
 
 
Figure 2. (A) Classical view. Classical concept of neurotransmission in the 1960s. Varicosities of 
noradrenergic terminals are involved in the synthesis, storage and calcium-dependent release in 
response to the occurrence of an action potential. Postsynaptic receptors on effector cells. The 
generally held opinion was that nerve endings had no receptors. (1)—exocytotic release of NA; (2)—
noradrenaline transporter mediating neuronal uptake; (3)—effects on α-or β-adrenoceptors on effector 
cells; (4)—extraneuronal uptake; R—response; MAO—monoamine oxidase; COMT—catechol-O-
methyltransferase. (B) View in 2007. In addition to the well-established postsynaptic receptors of the 
effector organ, terminal varicosities possess α2-presynaptic receptors which modulate NA release 
through a negative-feedback mechanism which plays a physiological role in neurotransmission. 
Reprinted from Neurochemistry International, 52, Salomon Z. Langer, Presynaptic autoreceptors 
regulating transmitter release, 26–30, Copyright (2008), with permission from Elsevier.  
(http://www.sciencedirect.com/science/journal/01970186) 
 
α2-receptor subtype also mediates vasoconstriction [26]. This subtype, which is highly 
sensitive to ADR, appears to be predominantly extrasynaptic [26,28], where it may be  
the target of circulating cathecholamines rather than neuronally released NADR 
[27,28].  Furthermore, autoreceptors located presynaptically on the neuron itself 
regulate the sympathetic effect. Presynaptic α2-receptors modulate NADR release 
through a negative feedback mechanism [27,29] (Fig. 2). In contrast, presynaptic β2 
receptors facilitate positive feedback modulation [19,30,31].  
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1.3.3 Cardiovascular effects of Adrenaline 
All blood vessels have been found to have α- and β-receptors [32]. However, the 
relative abundance of each subtype varies in different tissues. In skin, renal and 
splanchnic circulations α- receptors predominate, but in the nutrient vessels in 
skeletal muscle, β2-receptors predominate [32].  In the heart, the β1- receptors prevail 
[15]. In contrast to NADR, a predominantly α- agonist, ADR stimulate both receptors, 
producing a mixed action [15]. The cardiovascular effects of ADR can be summarized 
into:  
- Increased heart rate and cardiac force of contraction (β1-effect).  
- Diversion of blood from the skin, renal, and splanchnic circulations (α-effect, 
vasoconstriction) to skeletal muscles where vasodilatation takes place (β2-
effect).  
- Expansion of the pulse pressure, as a consequence to the effects above, with 
an increase in systolic blood pressure and a decrease in diastolic blood 
pressure. 
- Venoconstriction, reducing the venous capacity (α-effect).  
 
The overall effect of ADR is to increase the output capacity of the human body. 
It should be acknowledged, however, that vasoregulation is a complex issue and that 
ADR might influence other vasoactive mechanisms and control systems as well, such 
as NO and endothelin. (See section 4.3 for a more detailed discussion) 
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1.4 BLOOD FLOW DETERMINATIONS IN HUMAN SKELETAL MUSCLE 
During a long period of time after its discovery, ADR was mainly regarded as a 
vasoconstrictor and hypertensor. However, as reviewed by Lundholm [33], this 
understanding was gradually opposed by increasing evidence that ADR actually causes 
vasodilatation in skeletal muscle, reducing the peripheral resistance. It has been 
demonstrated that ADR, when infused intravenously or intraarterially, causes an 
increased blood flow in skeletal muscle (cats) [33]. This vasodilatory ADR effect has 
been shown to be true also in humans [34,35], and different measuring devices have 
registered similar results. Freyshuss et al found an increase in limb blood flow 
(venous occlusion plethysmography) in humans in response to intravenous infusions 
of increasing concentrations of ADR [36]. An increase in skeletal muscle blood flow 
during intravenous infusion of ADR has also been found with the 133Xe-clearance 
technique [37,38]. However, exceptions to these unanimous results have been 
reported with the microdialysis ethanol technique. Rosdahl et al. found that ADR, 
when infused locally through a microdialysis catheter, causes vasoconstriction in 
skeletal muscle (rats) [6]. It has been speculated that this ADR-induced 
vasoconstriction might be due to either the local route of administration or by a 
higher local ADR concentration reached during microdialysis administration [5]. 
Recently, Widegren et al. came up with interesting findings when human skeletal 
blood flow was determined with three different methods simultaneously during an 
intravenous ADR infusion or a Mental Stress test (Stroop Colour Word test) [5]. 
133Xe-clearance and VOP registered an increase in blood flow during both 
interventions. However, the microdialysis ethanol technique registered an increase 
in blood flow during mental stress test but a significant decrease in response to the 
intravenous ADR infusion. They concluded that ADR causes vasoconstriction in 
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skeletal muscle when blood flow is measured with the microdialysis ethanol 
technique, irrespective of the mode of administration (referring to the previous 
finding by Rosdahl et al.). This paradoxal ADR-induced vasoconstriction can possibly 
be explained by the more extensive local trauma involved in the microdialysis 
technique, which may in some way shift the balance of vasoconstrictor and 
vasodilator effects of ADR.  
 
1.4.1 Venous occlusion plethysmography  
Venous occlusion plethysmography (VOP) has been used to study blood flow in 
human extremities for more than a century [1]. The method is non-invasive and the 
underlying principle is simple; by obstructing venous outflow, but not arterial inflow, 
the volume of the limb distal to the occlusion cuff will increase at a rate corresponding 
to the blood flow entering this part [39]. This elementary principle is valid as long as 
one records the expansion of the whole limb to which the blood can enter and from 
which the venous return is occluded. The original method lived up to this principle but 
required large rigid water jackets in which the entire limb was enclosed [1]. The 
currently used method represents an adaptation of this principle and employs 
mercury-in-rubber strain gauges that encircle a segment of the part being examined 
[40]. With this modification, the swelling of the entire volume of the extremity beyond 
the level of venous occlusion is no longer recorded. In this case, the assumption has to 
be made that the volume expansion of the segments covered by the strain gauges is 
representative of the volume of tissue distal to the occlusion cuff.  
The relationship between the transmural pressure (p) and the venous volume (v) is 
not linear and, furthermore, changes with an increasing sympathetic tone [41]. When 
the veins are in a relaxed state, the curve is S-shaped with a lower slope of the p/v 
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curve at high transmural pressure than at low pressure [7,42]. In contracted veins, 
the curve is shifted to the right (Figure 7, section 4.1), resulting in an increased 
venous pressure and lower venous volume. Depending on the position of the limb 
and whether the veins are in a relaxed or contracted state at the time of venous 
occlusion the obtained results will thus differ. This circumstance is a problem inherent 
in the strain gauge VOP method. Segments with low transmural pressure and almost 
collapsed veins will be able to expand more and faster than segments with 
contracted and/or filled veins. Furthermore, the p/v relationship is probably different 
in skin and muscle veins, the relative abundance of which also varies along the limb 
[43]. During VOP, the major portion of blood entering the limb after the venous 
occlusion accumulates in the veins, which act as communicating vessels. The 
swelling of a particular segment will, therefore, be dependent not only on the 
arterial inflow to it and the venous outflow from it, but also on the volume of the 
veins within that segment and the pressure–volume relationships of these veins in 
relation to adjacent communicating segments. Furthermore, the relative volume of 
veins within a segment is higher in segments with a high fraction of soft tissue, 
which varies along the limb.  
VOP has experienced a renaissance during the last few decades and is frequently used 
in various research situations, e.g. studies of endothelial function. The previously 
mentioned problem with segmental volume expansion recordings has become more 
immediate since many studies apply the VOP technique with one strain gauge per 
limb, and refer the obtained results as blood flow in the whole extremity.  
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1.4.2 Inert gas-clearance technique 
Clearance methods apply the principle that indicators diffusing freely across cell 
membranes can be used to measure local blood flow, since their clearance is 
determined by the blood flow only [2]. The diffusible tracer is mixed with saline and 
injected into the muscle under study. The radioactivity over the injection site is 
continuously monitored with an external gamma detector. After subtraction of 
background radiation all obtained values are converted into natural logarithms. 
These values are then plotted against time on a linear scale. Muscle blood flow, in 
ml min-1 100g tissue-1, can be calculated from this decay curve according to the 
equation:  
Muscle blood flow = λ * k * 100 
Where λ is the tissue to blood partition coefficient for the used isotope, and k is the 
slope of the least square linear fit. The clearance curve has an initial rapid phase 
followed by a fairly constant clearance rate which slowly decreases over time and 
finally ends up in a slow clearance rate (the tail part of the curve), see fig 3. The first 
about 30 minutes of the washout curve is considered to possibly be influenced by the 
injection trauma and therefore excluded [3]. The inert gas clearance method does not 
allow for blood flow determinations during prolonged measurement. It has previously 
been documented with the 133Xe clearance technique that values obtained at the tail 
part of the clearance curve yields an underestimation of the actual blood flow by 
several mechanisms [3], see Study III for details.  
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Figure 3. A typical clearance curve with an initial rapid washout phase, followed by a fairly constant 
clearance rate which subsequently ends up in a slow clearance rate at the tail part of the curve. The 
beginning and the end of the 30 minute ADR infusion is illustrated by event marks. 
 
Several radioactive tracers have been utilized in measuring skeletal muscle blood flow 
with this technique; most commonly 133Xe, which has been used for estimation of 
regional blood flow in human skeletal muscle since the sixties [2]. The 133Xe clearance 
technique has, at least to some extent, been regarded as “golden standard” for 
peripheral blood flow measurements in general. The reason for this is that it has been 
the only available method for determination of nutritive blood flow in humans. 
However, 133Xe has some disadvantages, as Seto et al. recently remarked [44]: Due to 
its lipophilic nature it is not sufficiently washed out of fat tissue which hampers 
precise measurement. Furthermore, it migrates easily from saline to air, thereby 
making it difficult to maintain the quality (radioactivity) of 133Xe solution. And finally, 
133Xe gas-containing saline has recently become commercially more or less 
unavailable. We experienced difficulties to obtain 133Xe solution for the forth study 
and were forced to find an alternative. Fortunately, Technetium has been proven to 
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be a satisfactory substitute. Its short-lived (half life 6 hours) gamma-emitting nuclear 
isomer 99mTcO4
- (metastable 99Tc pertechnetate) has good properties which facilitate 
fast elimination and thus little radiation burden to the body [44,45]. Pertechnetate is 
an oxoanion with the chemical formula TcO4
− which is used as a water-soluble source 
for carrying Tc isotopes [46], in particular the 99mTc. The disparity in the characteristics 
of 133Xe and 99mTc has been debated since it may influence the results of blood flow 
measurements [44,46-48]. The uncharged 133Xe (half life 5 days) can cross the 
endothelial membrane freely due to its lipophilic nature while the charged 
pertechnetate (99mTc O4
-) most likely have other transportation pathways from the 
extravascular space into the capillaries due to its highly hydrophilic nature [47,48]. 
This difference is said to make 133Xe clearance perfusion-limited while 99mTc clearance 
has been suggested to be diffusion-limited [47]. Diffusion-limitation increases with 
increasing perfusion, which may influence the recordings in absolute values during 
high perfusion, e.g. muscle exercise [47]. Still, the ability to detect relative changes in 
blood flow is probably comparable irrespective of isotope used, at least at rest.  
Furthermore, 99mTc is convenient to handle since it is less volatile than 133Xe, and is 
retained more stably in the saline within the syringe [44]. Another important 
advantage of 99mTc is the availability since it can be obtained at most larger hospitals 
at low cost [46].  
Technetium was discovered in 1937 with subsequent discoveries of its different 
isotopes [49]. 99mTc is nowadays commonly used in nuclear medicine for a wide 
variety of diagnostic tests and research [50]. The usage of 99mTc clearance for 
determination of skeletal muscle blood flow is however fairly recent [44,46], although 
early attempts were done in the seventies [45].  
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Technetium is a radioactive metal and not a radioactive gas as Xenon. The term inert 
gas clearance technique was accordingly changed into isotope clearance technique in 
order to be more correct when Technetium was used instead of Xenon (Study IV). 
 
 
1.5 AIMS OF THE THESIS 
 
General 
The general aim of this thesis was to further study blood flow regulation in human 
skeletal muscle under normal conditions and after a minor muscle trauma.  
 
Specific aims of the thesis 
• To characterize the effects of environmental temperature and limb position on 
blood flow in human extremities as determined by VOP. 
• To evaluate the effect of excluding the hand circulation during VOP on 
redistribution of blood in the forearm. 
• To study the effect of ADR on nutritive muscle blood flow in humans. 
• To determine if an inserted microdialysis catheter alters the effect of 
intravenously administered ADR on muscle blood flow. 
• To study if ADR induces decreased blood flow in a chronic muscle pain 
condition such as tennis elbow. 
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2 SUBJECTS AND METHODS 
 
2.1 ETHICS 
Study I was approved by the Local Ethics Committee at Linköping University. Study II-
IV was approved by the Local Ethics Committee at Karolinska Insitutet. The Isotope 
committee at Karolinska Hospital and Södersjukhuset approved Study III and IV, 
respectively. The experimental protocol in each study was explained to each subject 
and informed consent according to the Declaration of Helsinki was obtained from 
each individual prior to participation. 
 
2.2 SUBJECTS 
All subjects participating in Study I-III were healthy volunteers (n=6 in Study I-II, n=8 in 
Study III). In Study IV a healthy control group (n=8) was compared with a patient group 
suffering from tennis elbow (TE) (n=8). The subjects in the patient group were 
recruited at the outpatient clinic at the department of Hand Surgery, Södersjukhuset, 
Stockholm, Sweden. Information concerning eventual participation in Study IV was 
presented, in a strict manner, after decision regarding surgical treatment (ECRB 
elongation, “Garden procedure” [51]) for their distinct TE condition had been taken. 
No special treatment where given regardless of participation or not. All subjects, in 
both study groups, in Study IV volunteered. None of the subjects in the studies had a 
history of cardiovascular of peripheral vascular disease. All subjects were non-
smokers.  
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2.3 PROCEDURES 
2.3.1 Study I-II 
VOP employing mercury-in-rubber strain gauges were used in Study I-II. Both studies 
were carried out in a climate chamber in warm, normal and cold temperatures and 
40% relative air humidity (n=6 in both studies). Strain gauges were applied around 
four segments of the leg in Study I and three segments of the forearm in Study II. 
The varying positions of the limb in relation to the rest of the body were similar in 
Study I (leg) and Study II (arm) (i.e.; elevated 10˚, horizontal and lowered 15˚). A 
wrist cuff inflated to supra systolic pressure was used to exclude the hand circulation 
in half of the measurements in Study II. The varying limb positions were employed 
for affecting venous volume (gravity) and the different temperatures for altering 
transmural pressure (sympathetic tone). 
 
2.3.2 Study III 
Local blood flow in the gastrocnemius muscle was measured by 133Xe clearance 
during normal conditions and during i.v. infusion of ADR with or without the influence 
of a small muscle injury induced by inserting a microdialysis catheter. Three 
experiments at different occasions where carried out in the same subjects (n=8). In 
experiment 1, the 133Xe solution was administered conventionally by injection into 
the muscle via a thin intramuscular needle (diameter 0.4 mm). In the two other 
experiments (expt 2 and 3) a microdialysis catheter was introduced into the muscle 
through an insertion cannula (outer diameter 1 mm). A thin tubing was inserted 
along with the microdialysis catheter (see paragraph 2.4.4 for details). 133Xe was 
injected through the thin tubing, which thereafter was withdrawn while the 
microdialysis catheter was fixed and remained in place during the whole experiment, 
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but was not perfused. Radioactivity was measured with an external scintillation 
detector. Blood flow was determined at rest and during an intravenous infusion of 
ADR (0.1 nmol ⋅ kg-1 ⋅ min-1) (expt 1 and 2) and placebo (expt 3). 
 
2.3.3 Study IV 
Blood flow in the extensor carpi radialis brevis (ECRB) muscle was measured by local 
clearance of 99mTc.  Patients suffering from distinct TE was compared with healthy 
controls (n=8 in each group). Each subject was investigated on a single occasion in 
experiments where blood flow in the main portion of the ECRB muscle was measured 
before, during and after an intravenous infusion of ADR. The 99mTc injection procedure 
was carried out under sterile conditions by means of an ultrasonography guided 
muscle puncture (see paragraph 2.4.5 for details). The ADR (0.1 nmol ⋅ kg-1 ⋅ min-1) was 
infused intravenously (fossa cubiti) in the contra lateral arm during 30 minutes.  
 
2.4 METHODS 
2.4.1 Venous occlusion plethysmography, Study I-II 
Mercury-in-silastic rubber strain gauges were used and the relative change of the 
volume of the limb segments under the strain gauges was registered on two two-
channel chart recorders (Plethysmograph SP2; Medimatic, Copenhagen, Denmark). 
The strain gauges were calibrated at the different temperatures. The occlusion cuff 
was placed around the distal part of the thigh (Study I) and the upper arm (Study II) 
and the occlusion pressure was set at 50 mmHg. See the individual papers for 
specific strain gauge positioning. The strain gauges were connected to the two 
pletysmographs in a randomized fashion. The occluding proximal cuff was inflated 
for about 45 s and then deflated, the measurements being done on the linear part of 
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the curve during the first 30 s. This cycle was repeated six times during 10 min for 
each set of determinations and the mean value was used. A wrist cuff, inflated to 
supra-systolic pressure (220 mmHg) prior to the venous occlusion, was used in half 
of the measurements in Study II for exclusion of the hand circulation.  
 
2.4.2 Xenon and Technetium clearance, Study III-IV 
The isotope clearance method was used for determinations of muscle blood flow in 
the gastrocnemius muscle (Study III, 133Xe) and the ECRB muscle (Study IV, 99mTc), 
see section 1.4.2 for methodological details. The radioactivity over the injection site 
was continuously monitored with an external gamma detector (see section 2.4.7). 
The first 30-35 minutes of the washout curve is considered to possibly be influenced 
by the injection trauma and was thus excluded. The following 10 min was used as 
basal period (the 35-45 min period in Study III, the 30-40 min period in Study IV). The 
basal period was followed by the 30 min ADR infusion. Placebo was infused instead 
of ADR in Study III, experiment 3. After subtraction of background radiation all 
obtained values were converted into natural logarithms. These values are then 
plotted against time on a linear scale. Muscle blood flow, in ml min-1 100g tissue-1, 
was calculated from this decay curve according to the equation:  
Muscle blood flow = λ * k * 100 
Where λ is the tissue to blood partition coefficient for the used isotope, in our case 
133Xe and 99mTc [44,46,52], and k is the slope of the least square linear fit.  
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2.4.3 Radioactive tracers, used in Study III-IV 
Study III 
Approximately 35 μCi (1.3 Mbq) of 133Xe dissolved in 100-200 μl of isotonic saline was 
delivered in a glass ampoule from the Pharmacy at Karolinska hospital, Stockholm, 
Sweden. The 133Xe solution was injected after withdrawal from the ampoule. 
Study IV 
99mTechnetium pertechnetate was extracted from a generator at the department of 
Nuclear medicine, Södersjukhuset, Stockholm. About 0.1 ml of the isotope solution, 
with an activity of approximately 10 MBq/0.1 ml, was delivered in a 1 ml syringe.  
 
2.4.4 Catheter insertion and 
133
Xe injection, Study III 
In two of the experiments in Study III (expt 2 and 3) a microdialysis catheter was 
introduced into the muscle using the “guide tubing procedure”[53]. This involves the 
insertion into the muscle (parallel to the muscle fiber direction) of a steel cannula with 
a plastic guide tubing fitted on the outside (outer diameter 1.0 mm). This is followed 
by withdrawal of the steel cannula leaving the guide tubing in place in the tissue, 
through which the microdialysis catheter is inserted. Along with the microdialysis 
catheter a thin tubing (outer diameter 0.15 mm) was inserted through the guide 
tubing, to the level of the middle of the membrane part of the microdialysis catheter. 
When the microdialysis catheter plus the thin tubing had been inserted, the plastic 
guide tubing was removed by splicing upon retraction. 133Xe was then injected via the 
thin tubing which thereafter was removed. The microdialysis catheter was fixed and 
remained in place during the whole experiment, but was not perfused.  
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2.4.5 Ultrasonography guided muscle injection, Study IV 
An Acuson Sequoia 512 ultrasound apparatus with a transverse (linear) 8 MHz 
transducer was used for an ultrasonography guided 99mTc injection in the main portion 
of the ECRB muscle (Fig. 4-6). The subjects were placed in a comfortable sitting 
position with the forearm resting on a table. The injection procedure was carried out 
under sterile conditions. The forearm was prepared and a needle guide was clipped on 
to the transducer.  Adjacent muscles around the ECRB was identified and avoided 
during the injection procedure. The extensor digitorum communis muscle was easily 
located by letting the subject move their fingers. The extensor carpi radialis longus 
muscle was visualized lying partly superficial and radial to the ECRB muscle. 
Subsequently, the main portion of the ECRB muscle was identified in the dorsal 
aspect of the proximal forearm (between the proximal and middle third of the ECRB 
muscle, about 8-10 cm distal to the lateral humeral epicondyle). A 25 gauge (0,5 mm) 
and 3½ inch (90 mm) long spinal needle (BD Medical, Franklin Lakes, NJ, USA) was 
advanced through the needle guide into the central part of the muscle where 
approximately 0.1 ml of the isotope solution (10 MBq/0.1 ml) was injected slowly. 
With the needle kept in place, the syringe was filled with a small amount of air (about 
0.1 ml) which also was injected in order to empty the needle and inject as much of the 
isotope as possible. After completed injection, the needle was held in position during 
1 minute and then pulled out in a stepwise fashion, in order to avoid the isotope 
from flowing back through the injection channel. 
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Figure 4. Ultrasosgraphy guided 
99m
Tc injection in the ECRB muscle. The needle guide on the transducer 
enables a precise injection in the main portion of the muscle. 
 
 
Figure 5. A cross sectional view of the dorso-radial part of the proximal forearm (ultrasonograhy, right 
arm). The ECRL muscle (extensor carpi radialis longus) is located partly superficial and radial to the ECRB 
muscle. The supinator muscle insertion to the radius is seen deep to the ECRB muscle. The major tick 
marks to the left represents 1 cm in between. 
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Figure 6.  Immediately after the 
99m
Tc injection in the main portion of the ECRB muscle. The white dots 
represent the injection “channel” into which the needle is guided. The needle tip is seen in the upper 
right corner. The injected 
99m
Tc is visible as a darker area just distal to the needle tip (arrow). 
 
 
2.4.6 Monitoring of heart rate and blood pressure 
Study III 
Heart rate was continuously monitored throughout Study III by telemetry using the 
Polar Sport Tester heart rate monitor (Polar Electro, Kempele, Finland). Heart rate 
data were averaged over 1 minute periods. A tourniquet was placed on the upper, 
non-infused, arm for intermittent blood pressure monitoring.   
Study IV 
Heart rate and blood pressure were measured intermittently, every third minute, 
during the whole procedure using a wrist cuff (Omron R3, Omron Healthcare Europe,  
Hoofddorp, the Netherlands) on the infused arm, distal to the intravenous infusion 
access.  
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2.4.7 Scintillation detector 
Measurement of radioactivity, Study III-IV 
The detector, a Sodium Iodide crystal (Canberra, Uppsala, Sweden) ∅ 43 mm, was 
located 8 cm inside the opening (∅ 34 mm) of a surrounding lead cylinder, which was 
placed perpendicular to and adjoining the surface of the skin. Radioactivity was 
measured each second period and expressed as counts min-1 (cpm).  
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3 RESULTS 
3.1 STUDY I-II 
VOP with multiple strain gauges were used for blood flow determinations in the 
upper and lower extremity at varying environmental temperature (high, low or room 
temperature) and limb position (elevated, horizontal or lowered). Most of the 
tendencies observed in Study I were more distinctly demonstrated in Study II. 
However, a few differences in obtained results in the two studies require some 
clarification.  
Study I 
The major finding of Study I was that the mutual relationship between the swelling 
rates of individual segments is dependent on the environmental temperature and 
the position of the leg.  
Influence of temperature (sympathetic tone)  
Environmental temperature clearly influenced the obtained values (high values at 
high temperature and low values at low temperature) and the influence was more 
distinct the more distal the strain gauge was positioned. 
Influence of limb position (intravasal pressure) 
With the leg in the lowered position, the values obtained were decreased, on 
average to 68% of that recorded at the horizontal position. There was a general 
trend for the magnitude of this decrease to become progressively larger the more 
distal the segment was situated. Elevating the leg resulted, in most cases, in an 
increase in calf volume expansion rate. This effect on volume expansion rate by 
changing leg position was accentuated at warm, and tended to be decreased at cold 
temperature.  
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Influence of strain gauge position 
In all nine combinations, there was a clear tendency towards higher segmental 
volume expansion rate values at the maximal circumference of the calf relative to 
the proximal and distal calf levels, regardless of the temperature of the room and leg 
position.  
Study II 
A wrist cuff was used in half of the measurements in Study II, for exclusion of the 
hand circulation. The obtained results differed in several aspects when hand 
circulation was included or excluded:  
The simple main effect of temperature was highly significant (P<0.001) in both 
settings (high values at high temperatures and low values at low temperature). 
With excluded hand circulation (but not when included), there was a significant two 
factor interaction between arm position – strain gauge position (P<0.05), which was 
independent of temperature since the three factor interaction was non-significant. 
The highest expansion rate was found in the proximal segment when the arm was 
elevated, but in the distal segment when the arm was lowered. This pattern was 
found in all temperatures, but was not seen in Study I (lower limb). 
With hand circulation (but not without) there was a significant two factor interaction 
between temperature and strain gauge position (P<0.01), which was independent of 
the positioning of the arm since the three factor interaction was non-significant. 
The highest expansion rate was found in the distal segment at normal and high 
temperatures, but in the proximal segment at low temperature. This pattern was 
found with all arm positions. In Study I (lower limb) the highest expansion rate was 
generally found at the maximal circumference of the calf (relative to the other calf 
segments). 
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3.2 STUDY III 
Heart rate and blood pressure 
In the absence of plasma adrenaline measurements, heart rate and blood pressure 
were recorded to document the systematic reaction to adrenaline in Study III and IV. 
The ADR-infusions in expt 1 and 2 generated a moderate increase in heart rate (about 
3-5 beats per minute). The increase was statistically significant in expt 1, p<0.05. 
Furthermore, the pulse pressure expanded significantly in both expt 1 (p<0.001) and 2 
(p<0.05), although the changes in systolic and diastolic blood pressure did not achieve 
statistical significance. The placebo infusion in expt 3 did not influence heart rate and 
blood pressure. 
 
Blood flow 
Muscle blood flow tended to increase with the adrenaline infusion in expt 1 (i.v. ADR 
infusion, 133Xe deposited normally in the muscle, no microdialysis catheter inserted) 
from 1.17 ± 0.10 (basal) to 1.39 ± 0.15 ml min-1 100 g tissue-1  (6–15 min into the 
infusion period), N.S. On the contrary, in expt 2, the blood flow decreased during the 
identical ADR infusion (i.v. adrenaline infusion, 133Xe deposited close to an inserted 
microdialysis catheter in the muscle) from 1.39 ± 0.14 to 1.03 ± 0.14 ml min-1 100 g 
tissue-1, P<0.001. The blood flow change in response to the ADR infusion was 
significantly different in expt 1 and expt 2 (P<0.05). Blood flow also decreased during 
the placebo infusion in expt 3 (control experiment with placebo infusion, 133Xe 
deposited close to an inserted microdialysis catheter in the muscle), from 1.15 ± 0.10 
to 1.00 ± 0.09 ml min-1 100 g tissue-1, P<0.01. The blood flow decrease in response to 
ADR infusion in expt 2 was significantly larger than during the placebo infusion in expt 
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3, P<0.01. Basal blood flow values were not significantly different in the three 
experiments. 
There was a gradual and constant decrease in the rate of 133Xe-clearance over time in 
all three experiments, only interrupted by the adrenaline-induced effects which were 
most pronounced during the 6–15 min period of infusion (expts 1 and 2). A continuous 
decrease in clearance rate during the measurement period is expected and is a 
characteristic feature of the isotope clearance method; see the Discussion section 4.2 
for details and references.  
 
3.3 STUDY IV 
Heart rate and blood pressure 
Basal heart rate levels were similar in the two study groups, 63.4 ± 3.0 (patients) and 
65.8 ± 3.5 (controls), and increased about 10 bpm in both groups during the 30 min 
period of intravenous adrenaline infusion (p<0.01). The heart rate returned towards 
basal after the adrenaline infusion. Basal levels of heart rate were obtained after 
about 15 min of the recovery period. 
The systolic blood pressure had a tendency to increase and the diastolic blood 
pressure to decrease during the intravenous adrenaline infusion. This resulted in a 
tendency towards increased pulse pressure in both groups during the adrenaline 
infusion (statistically significant in the control group during the 16-30 min interval as 
well as during the recovery period). 
 
Blood flow  
A continuous decrease in isotope clearance rate over time is expected and a 
characteristic feature of the isotope clearance technique (see the Discussion section 
4.2 for details and references). 
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In the control group, this decrease was interrupted by the adrenaline-induced 
vasodilatory effects which were most pronounced during the first 15 min of the 30-
min infusion period. No such effect was detected in the patient group. The different 
pattern of blood flow change in response to the adrenaline infusion in the patient and 
control groups, respectively, was highly significant (statistical interaction group * 
effect, p<0.002). Mean values of 99mTc clearance rate during the 0-15 min of the 
adrenaline-infusion period was 55.9 ± 5.9 % of basal in the patient group and 97.4 ± 
4.1 % of basal in the control group (p<0.001). Basal 99mTc clearance rates was similar in 
the two groups and corresponded to a muscle blood flow of 2.71 ± 0.39 and 2.54 ± 
0.55 ml ∙ min-1 ∙ 100 g tissue-1 in Patients and Controls, respectively.  
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4 DISCUSSION 
As outlined in the introduction, blood flow determinations in human skeletal muscle 
are not easily made. The present series of experiments highlights a number of 
methodological problems with VOP and the microdialysis ethanol technique. 
Furthermore, the experiments also emphasize that these methods are dependent on 
sympathetic tone, which may influence the obtained results considerably if not 
appreciated. In addition, by studying these problems and by applying our findings to 
a chronic muscle injury we have found evidence indicating a possible pathological 
process within the ECRB muscle of patients suffering from TE.  
 
4.1 METHODOLOGICAL ASPECTS ON VOP (STUDY I-II) 
In Study I-II, venous occlusion plethysmography (VOP) was used for measuring 
volume expansion rate in the upper and lower extremity. It should be stressed that 
the VOP method detects the volume expansion rate of a limb and not the actual 
blood flow in a particular muscle, hence making the method relatively unspecific. On 
the other hand, the technique is easy to use, non-invasive and fairly reproducible if 
handled properly. The modern form of the VOP method employs mercury-in-rubber 
strain gauges that encircle a segment of the part being examined. With this 
modification of the original method, which enclosed the whole limb, the assumption 
has to be made that the volume expansion of the segments covered by the strain 
gauge is representative of the volume of tissue distal to the occlusion cuff. The 
potential pitfalls inherent in the method with this assumption are clearly 
demonstrated in Study I-II, especially if only one strain gauge is applied.  
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The fundamental circumstance on which both of these studies were based is that 
the relationship between the transmural pressure (p) and the venous volume (v) is 
not linear and, furthermore, changes with an increasing sympathetic tone. The 
venous volume expansion rate is determined by the arterial inflow and the capacity 
for venous expansion. The latter is determined by the position on the venous 
pressure-volume curve at any given time and eventual redistribution of venous 
blood to or from a particular segment. Hence, depending on the position of the limb 
and whether the veins are in a relaxed or contracted state at the time of venous 
occlusion the obtained results will differ. When the veins are in a relaxed state, the 
pressure-volume curve is S-shaped with a lower slope of the curve at high 
transmural pressure than at low pressure. In contracted veins, the curve is shifted to 
the right. The results in Study I-II indicate that the venous blood was redistributed 
from segments with a high transmural pressure and, therefore, low compliance, to 
segments with a lower transmural pressure and, therefore, higher compliance.  
The changes in temperature were used to obtain low, intermediate and high 
sympathetic activation of the venous vasculature. At low sympathetic activation 
(high temperature) the positioning on the venous pressure-volume curve is far to 
the left (see Fig. 7). In this position the capacity for venous expansion is maximal 
since the veins are almost empty and the VOP consequently registers the highest 
values at the highest temperatures.  
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Figure 7. Schematic representation of vein distensibility in a relaxed (upper curve) and maximally 
contracted (lower curve) state. The change in cross-sectional profile at different pressure (relaxed 
state) is indicated schematically at the top of the figure.  
(Modified from An Introduction to Cardiovascular Physiology by J. R. Levick, reprinted by permission of 
Elsevier Science Limited. Data points for isolated canine saphenous vein reprinted with kind 
permission from Springer Science+Business Media: Pflügers Archiv, The reactivity of isolated venous 
preparations to electrical stimulation, 306, 1969, 341–353, Vanhoutte P. M. and Leusen I, figure 5. 
Reprinted with kind permission from Dr P. M. Vanhoutte.) 
 
Reproduced with permission, from Jorfeldt et al., (2003), Clincal Science, 104, 599–605 
 © the Biochemical Society (http://www.clinsci.org) 
 
Another way to obtain a position on the far left side of the venous pressure-volume 
curve is to keep the limb elevated. This is well illustrated by the data obtained in 
Study I; with elevated leg and with the veins in a relaxed state (warm temperature) 
the distal thigh showed a relatively low expansion rate, whereas the calf segments 
showed a high expansion rate. This is in line with a relatively lower initial transmural 
pressure in the distal calf segment (which is elevated) compared with that of the 
distal thigh segment at the start of venous occlusion. At this time, the veins of the 
distal calf, therefore, are empty and in an almost collapsed, state. During occlusion, 
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this particular segment, therefore, has the ability to increase its volume much more 
than the more proximal segments.  
Furthermore, it is likely that venous outflow occurs to more proximal segments as 
well. Therefore the swelling of a segment depends not only on the arterial inflow, 
but also on redistribution of venous blood. The veins will act as communicating 
vessels, and the expansion of a segment after more proximal venous occlusion 
depends on the total compliance of the capacitance vessels within the segment and 
the time constant for translocation of venous blood to and from that segment. An 
example regarding the influence of limb position can be found in a report from Rojek 
et al. [54] who studied forearm blood flow (FBF) with VOP using a single strain gauge 
positioned about seven cm distal to the olecranon. FBF was measured at rest and 
during dynamic hand grip contractions with the arm 10 cm above and below the 
level of the heart. They found a significantly lower FBF reading at rest when the 
forearm was placed below the level of the heart than compared with above, which is 
in accordance with our findings. Conversely, during exercise, the FBF values were 
significantly higher below the level of the heart, compared with above [54].  
 
An interesting exception to the general pattern of reaction occurred in Study II when 
the hand circulation was excluded and the arm was elevated. According to the 
principle that elevation of the limb empties the veins, especially in the distal part, 
the expected result would have been an increase in volume expansion rate in the 
distal segment. On the contrary, the values obtained were lower in the distal 
segment as compared with the more proximal segments. A possible explanation to 
this might be related to the venous drainage of the hand and its topographical 
anatomy. The venous drainage of the hand is predominantly superficial through the 
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subcutaneous veins on the dorsum of the hand and further proximally, still 
superficial, through the Cephalic and Basilic veins in the forearm [55], whereas the 
deep venous system is relatively more involved in the venous drainage of the 
forearm [56]. The cross sectional area of the distal forearm segment is dominated by 
less vascularized tissues (bone, tendons) while the muscle fraction predominates in 
the more proximal segments. The superficial venous system thus plays a relatively 
more important role in segmental volume expansion in the distal part of the forearm 
during VOP. As the wrist cuff is inflated and hand circulation is excluded the normal 
venous drainage to the large superficial veins in the forearm will be blocked and the 
filling of these veins will be dependent on communicating branches in between the 
deep and superficial venous systems during proximal venous occlusion (VOP 
measurement). One important communicating branch is the v. profundus cubitalis in 
the fossa cubiti [55,57,58]. A hypothetical explanation to our finding is that these 
communications are less sufficient in the elevated position of the forearm compared 
to the horizontal and lowered position. A mechanism behind this difference might 
be found in the competence of the venous valves. The valves are positioned to 
direct the blood from distal to proximal and from superficial to deep [57-59] and 
therefore some valvular incompetence is needed to enable the blood to flow in the 
opposite direction. According to the law of LaPlace, P = T⁄R, an infinite pressure 
would be demanded in order to increase wall tension (to enable some valvular 
incompetence) if the vein is fully collapsed [60]. This would explain the lower 
volume expansion rate at the distal segment when the arm is elevated (and the 
superficial veins collapsed).  
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Some concordance with this explanation can be found in an interesting anecdote 
regarding valvular incompetence in clinical practice. The distally based pedicled 
radial forearm flap (Chinese flap) with a reversed arterial blood flow caused 
astonishment in the Western world when it was introduced by Yang et al. in 1981 
[61]. It challenged the prevailing principals of flap surgery at the time. The arterial 
supply to the flap was straightforward with blood from the ulnar artery through the 
superficial palmar arc and in retrograde direction into the radial artery. The 
controversy was the venous drainage which was a mystery since the valves are 
situated to prohibit blood flow in distal direction. In order to accomplish retrograde 
venous return through the pedicle of the flap the valves had to be incompetent. 
However, the venous drainage worked and the flap has survived the test of time. 
According to the current theory [60] several factors are needed to enable valvular 
incompetence, of which two are: 
- A sufficient but not very high venous pressure 
- The maintenance of blood flow in the veins to avoid their flattening, because when 
a vein flattens the pressure to fill it up is infinite according to LaPlace´s law.  
 
We have shown that small variations in sympathetic tone and venous pressure can 
influence blood flow measurements, with the VOP technique, even in intra-
individual comparisons. This variability should be taken into account when strain-
gauge plethysmography is applied for limb blood flow determination, especially in 
interventional studies. As mentioned previously, VOP is frequently used with only 
one strain gauge attached to the limb and the results obtained are referred to as 
blood flow in the limb. Placement of the strain gauge at the maximal circumference 
of the limb with a distal occlusion cuff at the wrist or ankle is regarded as standard in 
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this technique [40,62,63]. However, even if the procedure is standardized in this 
manner, the results in Study I-II clearly demonstrates that events taking place under 
one strain gauge cannot be strictly duplicated in adjacent portions of the limb.  
 
4.2 METHODOLOGICAL ASPECTS ON THE ISOTOPE CLEARANCE TECHNIQUE 
(STUDY III-IV) 
Several radioactive tracers have been utilized in measuring skeletal muscle blood flow 
with the isotope clearance technique; most commonly 133Xe, which has been used for 
estimation of regional blood flow in human skeletal muscle since the sixties [2]. The 
133Xe clearance curve has an initial rapid phase followed by a fairly constant clearance 
rate which slowly decreases over time and finally ends up in a slow clearance rate (the 
tail part of the curve), see section 1.4.2 fig 3. Calculated blood flow from the steep first 
part of the clearance curve, immediately after the isotope injection, has been shown 
to overestimate the directly measured blood flow [3]. Accordingly, the first about 30 
minutes of the washout curve is considered to possibly be influenced by the injection 
trauma and should therefore be excluded. In addition, values obtained at the tail part 
of the 133Xe clearance curve yields an underestimation of the actual blood flow by 
several mechanisms [3,64-68], see Study III for details. Hence, the intermediate part of 
the clearance curves, when fairly accurate blood flow measurement can be obtained, 
is relatively short (about 30-45 min). However, despite these inherent limitations the 
isotope clearance method is sensitive in detecting relative blood flow changes [69] 
following some kind of intervention, e.g. an ADR infusion. Even with a slowly decaying 
isotope clearance curve (with clearance rate as ordinate and time as abscissa), an 
upward shift represents an increased clearance rate, which in turn indicates an 
increase in blood flow and thus a probable vasodilatation. Consequently, a downward 
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shift in the isotope clearance curve reflects a decrease in blood flow and therefore 
most likely a vasoconstriction.  
 
Determination of blood flow in skeletal muscle using 133Xe clearance has been widely 
used for nearly fifty years [2] while measurement of muscle blood flow based on 99mTc 
clearance is still fairly new in comparison [44,46,48]. The properties of the two 
isotopes have some differences (discussed previously in section 1.4.2); the charged 
99mTcO4
- (pertechnetate ion) has a hydrophilic nature while the uncharged 133Xe is 
much more lipophilic. Even so, the obtained isotope clearance curves in Study III 
(133Xe) and Study IV (99mTc) were similar in a general perspective with a gradual 
decrease in clearance rate over time, only interrupted by the events provoked by the 
ADR infusion.  
“Muscle blood flow” (ml min-1 100g tissue-1) is widely used as the unit of 
measurement in isotope clearance studies [2,3,44,68,70]. In accordance with this and 
for ease of comparisons with previous studies we used this unit in the third study [71]. 
However, considering the overestimation of blood flow at the initial rapid washout 
phase and the underestimation at the tail part of the curve, the obtained results with 
the isotope clearance technique does only in a short time interval correspond directly 
in absolute terms to the actual muscle blood flow. This is also illustrated by the 
continuously decaying clearance rate over time found in Study III-IV. The obtained 
clearance values and the relative changes in clearance rate provoked by the ADR 
infusion should thus be looked upon as qualitative rather than quantitative. 
Consequently, the unit of measurement was changed from “muscle blood flow” into 
“isotope clearance rate” in the forth study in order to be more correct.   
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4.3 SMALL MUSCLE INJURY - ALTERED EFFECT OF ADRENALINE (STUDY III) 
Several indications in the literature support the concept that a microdialysis 
catheter-induced trauma alters the balance of vasodilatory and vasoconstrictory 
influences of ADR, as proposed in Study III.  Hodges et al. recently reported that the 
cutaneous vascular response to whole body heating was diminished by the presence 
of an inserted microdialysis catheter [72]. Further evidence in the same direction is a 
study from Rosdahl et al. who noted that an ADR infusion through the microdialysis 
catheter resulted in vasoconstriction [6]. Moreover, Widegren et al. found a 
decrease in skeletal muscle blood flow in response to intravenous ADR infusion 
when determined with the microdialysis ethanol technique, although simultaneous 
measurements with 133Xenon clearance and venous occlusion plethysmography 
(VOP) recorded an increase in blood flow as expected [5].  
 
In Study III, the ADR infusion caused a significant decrease in blood flow when the 
133Xe deposit was administered next to the microdialysis catheter (insertion cannula 
Ø = 1 mm) (expt 1) whereas the muscle blood flow instead tended to increase with 
the ADR infusion when the 133Xe was injected conventionally with a thin 
intramuscular needle Ø ≈ 0.4 mm (no microdialysis catheter inserted) (expt 2). There 
was a small but significant decrease in muscle blood flow also during the placebo 
infusion (expt 3) (control experiment with placebo infusion, 133Xe deposited close to 
an inserted microdialysis catheter in the muscle). This decrease might possibly be 
due to the cold placebo infusion in combination with the characteristic continuous 
decrease in isotope clearance over time in the inert gas clearance technique. 
However, the blood flow decrease in response to ADR infusion in expt 2 
(microdialysis catheter inserted) was significantly larger than during the placebo 
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infusion in expt 3 (microdialysis catheter inserted). Basal blood flow values were not 
significantly different in the three experiments. Hence, the two ways of 133Xe 
administration revealed different blood flow reactions to ADR. First of all, there is a 
discrepancy in the magnitude of the trauma inflicted to the muscle in the two 
procedures. Secondly, the microdialysis catheter (in expt 2) stayed in place during 
the procedure while the thin needle (expt 1) was removed after the injection. 
However, it is not possible to determine if the actual presence of the catheter or the 
muscle injury per se is the most likely reason for evoking the adverse ADR effect in 
Expt 2. A potential explanation might be the combination of both. Furthermore, it 
might be suggested that an enhanced vasoconstrictory influence around a muscle 
injury is an appropriate physiological response when blood is directed to the 
muscles during sympathetic activation with high ADR levels.  
 
A possible mechanism behind this effect of a small muscle injury on the local tissue 
might be related to the complex constellation of the adrenergic receptors and their 
different locations [18,19,21]. Vasodilatation mediated by vascular β-adrenoceptors 
is the normally observed vascular response to intravenously infused ADR in human 
skeletal muscle [37,38]. Since the opposite reaction was seen close to a small 
muscular injury, in Study III, it is conceivable that the normal β-effect is either 
blunted and/or overridden by a vasoconstrictive α-effect, or by other mechanisms 
induced by the ADR infusion. Indirect support to the first scenario, that the catheter-
induced muscle trauma in some way blunts the β2-effect, can be found in a study by 
Bolli et al. who infused ADR in the brachial artery of healthy and hypertensive 
subjects following β-adrenergic receptor blockade and found that ADR caused 
vasoconstriction via activation of postsynaptic α2-adrenoceptors [73]. An enhanced 
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α-effect overriding the normal β-effect is the other conceivable scenario. It is 
possible that the imposed trauma could increase the concentration of ADR at 
receptors - not normally directly exposed to humoral ADR. These receptors may be 
(1) prejunctional β2-receptors [19,31] which facilitate NADR discharge through a 
positive feedback mechanism leading to vasoconstriction via postsynaptic α-
receptors and (2) postsynaptic α-receptors [27] (direct effect). Both α1 and α2 -
receptors are present postsynaptically in blood vessels, where they mediate 
vasoconstriction [27]. The anatomical location and the physiological role of the 
postsynaptic receptors are of particular interest. It has been suggested that the 
predominant α1-receptors are located primarily in the adventitial-medial border, 
accessible to neuronally released NADR, whereas the postsynaptic α2-receptors are 
located closer to the intima, and predominantly outside the synaptic region [29,74], 
where it may be accessible to circulating catecholamines rather than neuronally 
released NADR [27,74]. Studies in various vascular preparations have subsequently 
shown that both postsynaptical α-receptor subtypes can be innervated by 
sympathetic nerves and, therefore, this classification of the α1 and α2 -receptors by 
anatomical location should no longer be utilized [75]. Still, the anatomical location of 
the postsynaptic α2-receptor is interesting as a possible explanation to the finding in 
Study III. In addition, data from pharmacological studies in experimental animals 
indicate that α1-receptors are located primarily on larger resistance vessels, whereas 
α2-receptors are located distally on smaller arterioles [26]. Although this receptor 
distribution pattern has not been exactly documented in humans, recent data are to 
some extent consistent with this [26]. Hence, it is possible that postjunctional 
extrasynaptic α2-receptor located on distal terminal arterioles becomes more 
exposed to ADR following a minor muscle injury. Moreover, it has been suggested in 
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the literature that this α2-receptor is very sensitive to ADR [27]. Since ADR is a 
potent α-agonist [32,76] it could be suggested that if enhanced access is achieved to 
either one of the postsynaptic α -receptors, the effect of circulating ADR would be 
vasoconstriction instead of the expected vasodilatation mediated through the 
vascular β2-receptor. In addition, enhanced stimulation of the exquisitely sensitive 
prejunctional β2-receptors, which augments neuronal release of NADR [30,31], is 
also likely to be improved after a muscle trauma giving ADR extravascular access. 
 
It should be acknowledged, however, that vasoregulation is a complex issue and that 
perturbations induced by the inserted microdialysis catheter of several other 
vasoactive mechanisms may also be involved in the vasoconstrictive response to 
ADR seen in Study III. A considerable factor in this instance might be the 
endothelium which plays a direct role in vasomotor function by integrating the 
controlling factors: reflexes, humoral, and local factors [77]. Endothelial cells release 
several substances acting directly on vascular smooth muscle cells, causing either 
contraction (e.g. endothelin-1) or relaxation (e.g. nitric oxide (NO) and prostacyclin).  
The interaction between these opposing factors is complex; e.g. the synthesis of 
endothelin-1 is inhibited by released NO [77], prostacyclin facilitates NO release and 
in turn NO potentiates prostacyclin effects in smooth muscle [77]. Another relevant 
factor released by the endothelium is angiotensin II (AII) by means of hydrolyzing 
angiotensin-I through angiotensin converting enzyme (ACE). AII is a potent 
vasoconstrictor and antagonist to NO [78]. Besides its own vasoconstrictive effect, 
AII stimulates endothelin converting enzyme that degrades big-endothelin to 
endothelin-1 [78]. As can be seen, the interrelationship and balance between 
endothelium-derived agonists and antagonists is very complex and delicate. 
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However, for these mechanisms to have a role in the presently detected 
vasoconstrictive effect of the ADR infusion in Study III and IV, there has to be a 
connection between ADR (and the muscle injury) and these endothelium-derived 
factors. An interesting circumstance in this regard is that the β2-mediated 
vasodilatation is 30-40% dependent on NO in human limbs  [79]. In theory, a blunted 
NO effect could thus partly explain an absent β2-effect during the ADR infusion. 
Moreover, the synthesis of endothelin-1 can be initiated by a variety of factors 
including catecholamines [77,80]. Another possible factor to consider is the 
inflammatory reaction induced by the catheter insertion. In accordance with this is a 
recent report by Mellergård et al., who found increased release of cytokines after 
insertion of microdialysis catheters in the brain and suggested that this might be 
directly related to the insertion trauma [81]. In addition, it has been suggested that 
ADR affects the immune system on a cellular level as well as the secretion of 
cytokines. Direction and nature of the effects may depend on the time and dose of 
exposition to the catecholamine [82]. 
 
Furthermore, there are other indications in the literature to suggest that the local site 
of administration, i.e. which receptor site that is stimulated, may be important for the 
vasoconstrictor effect to appear. Uvnäs et al [83] conducted interesting studies where 
they used rezerpin to deplete sympathetic nerves from their NADR. They 
subsequently reloaded the neurons with intravenously injected ADR and upon 
stimulation of the nerves a vasoconstriction occurred. These findings suggested that 
ADR released by sympathetic nerve stimulation hits vascular receptors different from 
the receptors stimulated by ADR given intravenously. Several authors [76,84-86] have 
shown that infused ADR can be converted into a cotransmitter by neuronal uptake 
   43 
and on subsequent release augment the simultaneous discharge of NADR. It has also 
been demonstrated that local ADR administration (in a wide range of concentrations) 
on the outside of isolated blood vessels causes vasoconstriction, even if intravenous 
injection of ADR causes the same vessels to dilate [87]. Altogether, these indications 
may suggest that receptor sites not normally exposed to circulating ADR may be 
responsible for the adverse ADR effect seen in Study III. 
 
The microdialysis technique is used for a variety of different purposes in both 
research and clinical practice, e.g. neurosurgery, plastic and reconstructive surgery 
etc. Whether the purpose is blood flow measurements or sampling of extracellular 
substances, it is apparently important that the tissue in which the catheter is 
introduced is as unaffected as possible by the insertion procedure per se. If the 
insertion of a measuring-device changes the natural state of the tissue and, as 
demonstrated in Study III - the blood flow response to ADR, the obtained results 
might be compromised. Depending on the plasma ADR concentration at any given 
moment, which varies endogenously (se section 4.4 for details), the blood flow 
around the catheter may fluctuate.  
 
It is reasonable to believe that the adverse ADR effect is related to the degree of 
invasiveness. In this case, it could be expected that any type of invasive measuring 
device causing a muscle injury would possibly be able to provoke a similar reaction. 
The finding in Study III has a general physiological implication, but has also 
implications for the use of invasive techniques to investigate blood flow regulation in 
skeletal muscle. Although the microdialysis technique in previous studies has been 
able to adequately detect blood flow changes of various origin in resting skeletal 
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muscle and adipose tissue [4,88-91], the results in Study III indicate that caution is 
warranted when this technique is used in studies of blood flow regulation. 
 
4.4 CHRONIC MUSCLE DAMAGE - ALTERED EFFECT OF ADRENALINE (STUDY IV)  
The aim of the fourth study was to determine if a diffuse and widespread chronic 
“muscle injury” can change the balance of vasodilatory and vasoconstrictory 
influences of ADR, similar to the findings after an acute small muscle injury in Study 
III.  Our hypothesis was based on several reports about impaired muscle blood flow 
and morphological signs of muscle damage in chronic muscle pain syndromes in 
general and in the tennis elbow (TE) condition in particular.   
 
TE, often referred to as lateral epicondylitis, is one of the most common causes of 
chronic muscle pain in the upper extremity. The suffix “itis” in the term epicondylitis 
indicate a disorder of inflammatory origin, but recent comprehensive reviews have 
stressed that the condition is an overuse syndrome with a failed reparative process 
rather than active inflammation [92-94]. The term epicondylitis is thus a misnomer 
and several other names have been proposed and used for the disorder e.g. lateral 
epicondylagia [95], angiofibroblastic tendinosis [96] and lateral elbow tendinopathy 
[97-99], of which the latter is the latest contribution. The term tennis elbow, which 
originate from a report by Major in 1883 [100] and still persists as a colloquial 
eponym for this condition [101], is used as designation for the condition in this 
thesis. 
 
Although the aetiology is commonly related to repetitive overuse [102], the 
patophysiology of TE is still unclear [93]. The overall consensus is that the extensor 
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carpi radialis brevis (ECRB) muscle-tendon unit has a central role in the condition 
[51,92,93,102-104]. Previous studies of the disorder have mainly focused on the 
painful extensor origin at the lateral epicondyle and histological changes within the 
ECRB tendon [96,105-107]. The vascularity of the proximal ECRB tendon has been 
studied in detail. Schneeberger and Masquelet found that the undersurface of the 
tendon seemed macroscopically avascular [108]. Bales et al. delineated the 
microvascular blood supply further and reported 2 hypovascular zones: one at the 
lateral epicondyle and the other 2-3 cm proximal to the ECRB origin, still in the 
tendon [109]. Several studies report degenerative changes in the ECRB tendon with 
dense populations of immature fibroblasts and signs of non-functional vascular 
hyperplasia [93,109]. These changes have been suggested to evolve due to 
insufficient blood supply resulting in failed attempts to heal an injury after a 
repetitive microtrauma [109]. The term angiofibroblastic hyperplasia/tendinosis 
originate from these histological findings [96,110]. Furthermore, Ljung et al studied 
the autonomic innervation of the blood vessels of the ECRB tendon and reported an 
imbalance between vasoconstrictor and vasodilator innervation at the arteriolar 
level which may predispose to hypoxic degeneration of the tendon [111,112].  
However, during the last decade there has been an increase in reports about 
morphological and physiological abnormalities more distally, at muscle level. In ECRB 
muscle biopsies taken 5 and 10 cm distal to the lateral epicondyle in TE patients, Ljung 
et al. found moth-eaten muscle fibres (muscle fibres with an uneven distribution of 
mitochondrial enzyme activity), fibre necrosis and signs of de- and regeneration with a 
conversion of muscle fibres into more oxidative forms [113]. Hence, tissue damage 
and degeneration seems to be part of the TE condition also at muscle level. In support 
of an impaired blood supply at muscle level, Oskarsson et al. measured blood flow in 
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the ECRB muscle bilaterally in patients with unilateral tennis elbow and reported 
significantly lower blood flow levels on the affected side [114]. In a subsequent study 
they treated the same subjects with botulinum toxin to induce muscle relaxation and 
reported significant relief of pain at 3 and 12 months follow-up accompanied by 
improved intramuscular blood flow in the ECRB muscle [115]. Although these studies 
do not indicate whether the blood flow impairment in TE is primary or secondary, they 
support the concept that a change in the balance between vasoconstriction and 
vasodilatation in the ECRB muscle may be central in the TE condition. The shift 
towards vasoconstriction with ensuing hypoxia may thus explain why TE often 
becomes chronic and difficult to treat. In further support of a vascular disturbance in 
TE, a slow reperfusion response in the ECRB muscle after release of an upper arm 
tourniquet has been noticed on the painful side in patients with unilateral tennis 
elbow (Ljung et al, unpublished data, Laser Doppler single fibre technique with on line 
registration of blood flow). In addition, Smith et al. found a local dysfunction of the 
sympathetic blood flow control in the skin overlying the affected enthesis and 
suggested that it may be associated with the pathogenesis in TE [116]. Taken 
together, the whole ECRB muscle-tendon unit is involved in the TE condition and the 
recent findings at muscle level emphasize the complexity of the disorder. This is also 
underlined by the multitude of operative and non-operative treatment options and 
their response (and non-response) which indicate that our understanding of the 
disorder currently is incomplete [93,101].  
 
The vascular reaction in response to the ADR infusion in Study IV was distinctly 
different in the two study groups, illustrated by the highly significant interaction 
effect (p<0.002). Whereas the ADR infusion did not significantly influence the blood 
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flow in the ECRB of controls, there was a significant decrease in 99mTechnetium 
clearance in the patient group. The result is in agreement with our hypothesis that 
the muscle damage in TE might shift the balance of vasoactive influences in the 
ECRB muscle in a vasoconstrictory direction. The result is also in accordance with the 
altered ADR effect seen in Study III after an acutely inflicted small muscle injury. The 
exact mechanism behind the vascular effect of a muscle injury cannot be 
determined and several different vasoactive systems may be involved as discussed 
in Section 4.3. The important finding is that this mechanism is present also in the TE 
condition. Evidently, it seems to be a distinct association between a small muscle 
injury, acute or chronic, and an abnormal blood flow reaction to adrenaline.  
 
A moderate increase in muscle blood flow is normally reported following 
intravenous ADR infusion in a dose equivalent to what we used in Study III-IV. This 
was also found in a previous study from our group [5], but could not be reproduced 
in Study III-IV even though a tendency towards an increased blood flow during the 
first 15 min of ADR infusion was seen in the control group in Study IV (fig 2, Study IV) 
and when conventional 133Xe administration was used in Study III (fig 1 (expt 1), 
Study III). 
 
It is possible that the muscle damage in the TE condition in some way blunts the 
vasodilatation mediated by β-adrenoceptors (or by other mediators) and therefore 
makes the tissue more reactive towards vasoconstrictive influence, such as α-
adrenergic stimulation. Other possible mechanisms behind the adverse ADR effect in 
the ECRB muscle of TE might be similar to the alternatives discussed in section 4.3 
regarding an acute small muscle injury. As suggested previously, an enhanced 
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vasoconstrictory influence around a muscle injury might possibly be an appropriate 
physiological response in situations with high ADR levels in plasma. 
 
In Study IV we used an ultrasonography guided muscle puncture in order to be 
absolutely certain that the 99mTc was administrated in the central portion of the 
ECRB muscle. The cross sectional depth and width of the ECRB muscle at this level is 
approximately 1.5 and 4 cm, respectively (see figure 5, section 2.4.5). The muscle is 
located ulnar and partly deep to the ECRL muscle and superficial to the Supinator 
muscle. Hence, ultrasonography guidance is vital in order to be exact with the 
muscle puncture. In addition, with the findings of Study III in mind, special 
precautions were taken to minimize the injection trauma and avoid the injection 
injury per se to alter the ADR effect. The injection was performed in a single 
puncture procedure by an experienced radiologist (MW) with a thin needle (0.5 mm 
in diameter) and only 0.1 ml of 99mTc solution was injected.  
 
The gradual decrease in isotope clearance rate over time could give the impression 
that the blood flow reaction in the TE group during the adrenaline infusion was an 
absence of vasodilatation only. An additional control group with TE patients infused 
with placebo would have been necessary to confirm that a vasoconstriction had 
indeed occurred in the TE group. Such a confirmation of the vasoconstrictive effect 
of the muscle injury was obtained in Study III [71].  
 
The altered ADR effect, seen in Study IV, indicates a vascular dysregulation in TE, 
which is likely to be of clinical significance by contributing to the development and 
maintenance of the chronic muscle pain in this large patient group. Ischemia is well 
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known to cause pain and the human skeletal muscle is vulnerable for hypoxia. Since 
ADR is an endogenous stress hormone it is tempting to believe that the ECRB muscle 
experiences recurrent hypoxia or even ischemia on daily basis in patients with an 
established tennis elbow disorder. However, the obtained results cannot be directly 
extrapolated to a defined physiological situation, such as psychosocial stress. In the 
latter situation, the predominant physiological response is an activation of the 
cardiovascular system by the sympathetic nervous system leading to a profound 
increase in heart rate and blood pressure, but where the contribution of the limited 
(two-fold or less) increase in the plasma ADR concentration is relatively small [117]. 
With the presently used ADR infusion, the concentration of ADR in arterial plasma 
will increase by 8-10-fold [118], but with a much smaller increase in heart rate than 
during mental stress, and with small or non-existent increases in systolic blood 
pressure and perceived stress [117,118]. Irrespective of these differences, there is 
evidence that the increase in the plasma ADR concentration that occurs during 
mental stress is large enough to influence the vascular resistance and blood flow in 
skeletal muscle [119]. Another situation in which the plasma ADR concentration will 
influence blood flow in skeletal muscles is physical exercise, where the ADR level in 
plasma may increase by 6-7-fold [120]. Therefore, the altered blood flow response 
to ADR in the ECRB muscle in tennis elbow, as shown in Study IV, may still be of 
direct importance in everyday situations.  
 
The present results may furthermore be extrapolated to other conditions involving 
widespread and diffuse muscle damage with signs of disturbed mitochondrial 
function and increased reliance of non-oxidative metabolism [113], such as myalgia 
of the shoulder (m. trapezius) and neck. Also in these conditions, there is evidence 
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that microcirculatory impairment is of central importance for the occurrence of the 
symptoms [121-123]. In light of such data, and in accordance with the present 
findings, it has been proposed that impaired muscle blood flow and its 
consequences on the cellular level might have a general implication on chronic 
muscle pain in humans [124]. 
 
Most patients with TE recover spontaneously within a year [93] and conservative 
treatment is the cornerstone in dealing with this large patient group [102]. However, 
in a small fraction of these patients the condition becomes chronic and surgery 
might be indicated. Several of the operative procedures to treat TE involves some 
kind of release or lengthening of the ECRB tendon [93], such as the Z-lenghtening of 
the distal ECRB tendon introduced by Garden 1961 [51]. The latter procedure has 
been shown to produce a significant sarcomere shortening [125] and is considered 
to relieve the mechanical stress on the painful muscle origin. However, based on the 
present results it could be suggested that an important effect of the procedure is 
related to an increased blood flow in the ECRB muscle, which is facilitated by the 
relative muscle relaxation after the tendon lengthening.  
 
The TE condition is generally looked upon as an overuse syndrome with 
degenerative changes in the proximal ECRB tendon. Study IV underlines that the 
ECRB muscle is also involved in the disorder and that TE is associated with a vascular 
dysregulation at muscle level. New ways of thinking about the condition may be 
required and even pharmacological treatment might be an option to improve the 
blood supply and turn a possible vicious circle of pain-muscle damage-impaired 
blood flow-increased pain etc, which may be an important feature of the condition. 
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4.5 CLINICAL IMPLICATIONS 
 
• VOP is frequently used with only one strain gauge attached to the limb and the 
results obtained is referred to as blood flow in the limb. Placement of the 
strain gauge at the maximal circumference of the limb with a distal occlusion 
cuff at the level of the wrist or ankle is regarded as standard in this technique. 
However, even if the procedure is standardized in this manner, events taking 
place under one strain gauge cannot be strictly duplicated in adjacent portions 
of the limb.  
 
• Small variations in sympathetic tone and venous pressure can influence 
blood flow measurements with the VOP technique, even in intra-individual 
comparisons. This variability should be taken into account when strain-gauge 
plethysmography is applied for limb blood flow determination, especially in 
interventional studies. 
  
• Enhanced vasoconstrictory influences around a muscle injury may be an 
appropriate physiological response when blood is directed to the muscles 
during sympatho-adrenal activation.  
 
• Both an acute small muscle injury (Study III) and a widespread and diffuse 
muscle damage, such as in the ECRB muscle of TE patients (Study IV), causes an 
abnormal blood flow reaction to ADR. 
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• The adverse ADR effect caused by the inserted microdialysis catheter in 
Study III may be related to the degree of invasiveness. In this case, it would 
be expected that any type of invasive measuring device causing a small 
muscle injury would possibly be able to provoke a similar reaction.  
 
• Whether the vasoregulatory alteration observed in Study IV represents the 
primary aetiology in TE or is a secondary effect of the muscle injury cannot be 
determined, but it is likely to contribute to the development and maintenance 
of the chronic muscle pain in this large patient group.  
 
4.6 FUTURE PERSPECTIVES 
 
• VOP employing only one strain gauge attached to the limb will most likely be 
one of the most common methods for determination of limb blood flow also in 
the future. This is due to the relatively simple and non-invasive nature of the 
procedure. However, it is important to be meticulous in the placement of the 
strain gauge, the positioning of the limb and to avoid situations that alter the 
sympathetic tonus. 
 
• The 133Xe clearance technique for blood flow determinations in skeletal muscle 
is likely to be less common in the future as the isotope is becoming 
commercially unavailable. Meanwhile, the use of 99mTc clearance probably will 
increase since it is easy to obtain and have several other advantages compared 
to 133Xe. 
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• Microdialysis ethanol technique will still be a necessary technique in order to 
determine blood flow fluctuation during microdialysis experiments and 
furthermore be an alternative for determination of local blood flow in skeletal 
muscle, although caution is warranted in interventional studies especially if 
ADR is involved in the procedure. 
 
• After completion of Study IV all patients in the TE group underwent Z-
lenghtening of the ECRB tendon at forearm level (Garden procedure) [51]. 
This technique has been used as standard surgical treatment for chronic TE 
cases after failed conservative treatment during the last 10-15 years at the 
Hand Surgery department in Stockholm. The surgery, performed by the 
author (TV), was successful and all subjects had a complete recovery. The 
obvious follow up study would be to reinvestigate the TE group to find out if 
the ADR effect also is normalized. 
 
• After Z-lengthening of the ECRB tendon most patients recover and become 
more or less pain free within about three months postoperative. An even 
more interesting study would thus be prospective, investigating blood flow 
and ADR effect in the ECRB muscle in a new group of TE patients – 
preoperative and at several occasions during the recovery period, eventually 
being able to demonstrate a parallel improvement with normalization of the 
ADR effect and a simultaneous remission of the pain. 
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• If the altered ADR effect on muscle blood flow is normalized after a Garden 
procedure it may have profound impact on the understanding of the 
patophysiology behind the TE condition and may also be extended into other 
chronic muscle pain conditions as myalgia of the shoulder and neck. 
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5 CONCLUSIONS 
 
5.1 STUDY I 
The venous pressure-volume curve is S-shaped with a lower slope of the curve at 
high transmural pressure than at low pressure. In contracted veins, the curve is 
shifted to the right. Hence, depending on the position of the limb and whether the 
veins are in a relaxed or contracted state at the time of venous occlusion the 
obtained results will differ. The venous blood will be redistributed from segments 
with a high transmural pressure and, therefore, low compliance, to segments with a 
lower transmural pressure and, therefore, higher compliance.  
 
5.2 STUDY II 
The usage or non-usage of a distal wrist cuff during VOP for exclusion of hand 
circulation influences the results in several aspects. With included hand circulation 
the highest expansion rate was found in the distal segment at normal and high 
temperatures, but in the proximal segment at low temperature. This pattern was 
found with all arm positions. With excluded hand circulation, there was a significant 
two factor interaction between arm position – strain gauge position, which was 
independent of temperature. The highest expansion rate was found in the proximal 
segment when the arm was elevated, but in the distal segment when the arm was 
lowered.  
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5.3 STUDY III 
The microdialysis catheter-induced muscle trauma alters the balance of vasodilatory 
and vasoconstrictory influences of ADR in a vasoconstrictive direction. The adverse 
ADR effect is likely to be related to the degree of invasiveness and/or the presence of 
the catheter. Further studies are needed to find out if any type of invasive measuring 
device causing a muscle injury is able to provoke a similar reaction.  
This finding has a general physiological implication, but has also implications for the 
use of invasive techniques to investigate blood flow regulation in skeletal muscle. 
 
 
5.4 STUDY IV 
The altered ADR effect, seen in Study IV, indicates a vascular dysregulation in TE, 
which is likely to be of clinical significance by contributing to the development and 
maintenance of the chronic muscle pain in this large patient group. Whether the 
vasoregulatory alteration, which would be expected to involve recurring relative 
muscle ischemia, represents the primary aetiology in TE or is a secondary effect of 
the muscle injury cannot be determined. New ways of thinking about the condition 
may be required and even pharmacological treatment might be an option to 
improve the blood supply and avoid further damage to the affected ECRB muscle-
tendon unit.  
 
Evidently, it seems to be a distinct association between a small muscle injury, acute 
or chronic, and an abnormal blood flow reaction to adrenaline.  
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Abstract in Swedish 
 
Flera olika kontrollsystem är involverade i den komplexa regleringen av blodflöde i 
human skelettmuskel. Interaktionen mellan dessa där ett system kan dominera eller 
modifiera ett annat komplicerar ytterligare. Mätning av muskelblodflöde kan därför 
vara utmanande särskilt om man betänker att tillgängliga mätmetoder är behäftade 
med olika tillkortakommanden och begränsningar. Denna doktorsavhandling har två 
olika inriktningar inom detta område varav båda relaterar till effekten av sympatiskt 
tonus. 
De två inledande studierna belyser problemen med att använda venös ocklusions- 
pletysmografi med endast en strain gauge-slynga runt extremiteten. Denna 
modifiering av den ursprungliga metoden har uppenbara risker. Studie I-II påvisar att 
små variationer i sympatisk tonus och venöst tryck påverkar mätresultaten avsevärt. 
Den underliggande orsaken till detta är att förhållandet mellan tryck och volym i 
venerna inte är linjärt och det faktum att blod kan redistribueras mellan olika 
extremitetssegment. Resultaten demonstrerar tydligt att volymsexpansion i ett 
segment inte kan dupliceras och sägas gälla även intilliggande segment. 
De avslutande två studierna fokuserar kring möjligheten att en mindre muskelskada 
kan framkalla ett förändrat blodflödessvar på adrenalin. Flera rapporter indikerar att 
detta kan stämma. Vi undersökte om en akut tillfogad muskelskada (Studie III) och 
en kroniskt skadad muskel (Studie IV) förändrar adrenalinets effekt på 
muskelblodflödet. I enlighet med hypotesen gav den akuta muskelskadan orsakad av 
en inlagd mikrodialyskateter ett signifikant minskat blodflöde under intravenös 
adrenalininfusion (133Xenon clearance intill en inneliggande men oanvänd kateter). 
Om 133Xe injektionen administrerades konventionellt utan en kateter i muskeln, 
påvisades ingen signifikant blodflödesförändring. Den avvikande adrenalineffekten 
på blodflödet är troligen relaterad till graden av invasivitet. Alla typer av invasiva 
mätinstrument som orsakar en muskelskada borde därför kunna framkalla en 
liknande reaktion. Detta fynd har en generell fysiologisk betydelse men påverkar 
också användandet av invasiva mätmetoder vid studier av blodflödesreglering i 
skelettmuskel.  
Tidigare studier av tennis armbåge har visat att den involverade muskeln, extensor 
carpi radialis brevis (ECRB), uppvisar tecken till en diffus och utbredd muskelskada och 
ett minskat blodflöde. Vi genomförde en fall-kontroll studie (Studie IV) med hypotesen 
att muskelskadan i ECRB, hos patienter med tennisarmbåge, orsakar ett förändrat 
blodflödessvar på adrenalin. Muskelblodflöde mättes med 99mTechnetium clearance 
lokalt i ECRB muskeln i samband med en intravenös adrenalininfusion. I enlighet med 
hypotesen var blodflödessvaret distinkt olika i de två undersökningsgrupperna 
(statistiskt signifikant interaktion, grupp * effect). Adrenalinet gav inte någon 
förändring av 99mTechnetium clearance i kontrollgruppen men framkallade en  
signifikant minskning i tennisarmbågsgruppen. Den förändrade adrenalineffekten 
indikerar att det föreligger en störd kärlreglering i ECRB muskeln vid tennisarmbåge. 
Troligen kan detta ha klinisk betydelse i utvecklandet och underhållandet av den 
kroniska muskelsmärtan i denna stora patientgrupp. Om den förändrade 
kärlregleringen, som troligen kan orsaka återkommande relativ syrebrist i muskeln, 
representerar primärpatologin vid tennisarmbåge eller om den är sekundär till 
muskelskadan kan dock inte avgöras.  
Sammanfattningsvis, en mindre muskelskada, akut eller kronisk, förefaller kunna 
förändra blodflödessvaret på adrenalin i kärlsammandragande riktning.  
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